Rosemary Gazu

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Brigham and Women's Hospital(Current)

University of the Witwatersrand

Centre for the AIDS Programme of Research in South Africa

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Baylor College of Medicine Children’s Foundation

Rosemary Gazu is an author at Brigham and Women's Hospital specializing in antiretroviral therapy, reproductive health, and human immunodeficiency virus pharmacotherapy.

Publications per year

2023–2024

Publications

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

Lameck Chinula, Lauren Ziemba, Sean S. Brummel et al. · The Lancet HIV · 2023 · 29 citations · Full text

Medicine, Maternal Health, Obstetrics +16

Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial

Dhayendre Moodley, Rosemary Gazu, Thandeka Nkosi · The Lancet HIV · 2023 · 25 citations

Public Health, Maternal Health, Obstetrics +17

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum

Risa M. Hoffman, Sean S. Brummel, Lauren Ziemba et al. · Clinical Infectious Diseases · 2024 · 12 citations · Full text

Public Health, Maternal Health, Obstetrics +17

1–3 of 3